VERROW PHARMACEUTICALS INC has a total of 22 patent applications. Its first patent ever was published in 2006. It filed its patents most often in United States, EPO (European Patent Office) and Australia. Its main competitors in its focus markets pharmaceuticals are PHRIXUS PHARMACEUTICALS INC, THERAPRO TECHNOLOGIES INC and VAKCINA KFT.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 4 | |
#2 | EPO (European Patent Office) | 3 | |
#3 | Australia | 2 | |
#4 | Hong Kong | 2 | |
#5 | Japan | 2 | |
#6 | New Zealand | 2 | |
#7 | Brazil | 1 | |
#8 | Canada | 1 | |
#9 | China | 1 | |
#10 | Republic of Korea | 1 | |
#11 | Mexico | 1 | |
#12 | Singapore | 1 | |
#13 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Rowe Vernon D | 18 |
#2 | Mosher Gerold L | 3 |
#3 | Gerold L Mosher | 1 |
Publication | Filing date | Title |
---|---|---|
WO2013180777A1 | Stabilized formulations containing iodinated contrast agents and cyclodextrins | |
US2007270380A1 | Compositions useful for reducing nephrotoxicity and methods of use thereof | |
NZ592293A | Compositions comprising an oligosaccharide such as a cyclodextrin for reducing the nephrotoxicity of other drugs |